{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:54:18Z","timestamp":1782939258160,"version":"3.54.5"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH Vision Core Grant","award":["P30-EY01583\u201326"],"award-info":[{"award-number":["P30-EY01583\u201326"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04338-8","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:07:46Z","timestamp":1759230466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A systematic review of the study design and statistical practices in randomized controlled trials on myopia treatment (2019\u20132023)"],"prefix":"10.1186","volume":"25","author":[{"given":"Youvin","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Shuang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"1","key":"4338_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1475-1313.2011.00884.x","volume":"32","author":"CW Pan","year":"2012","unstructured":"Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt Jan. 2012;32(1):3\u201316. https:\/\/doi.org\/10.1111\/j.1475-1313.2011.00884.x.","journal-title":"Ophthalmic Physiol Opt Jan"},{"key":"4338_CR2","doi-asserted-by":"publisher","unstructured":"Morgan IG, Ohno-Matsui K, Saw SM, Myopia. Lancet. May 5 2012;379(9827):1739-48. https:\/\/doi.org\/10.1016\/s0140-6736(12)60272-4","DOI":"10.1016\/s0140-6736(12)60272-4"},{"issue":"5","key":"4338_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and Temporal trends from 2000 through 2050. Ophthalmology May. 2016;123(5):1036\u201342. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006.","journal-title":"Ophthalmology May"},{"issue":"4","key":"4338_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1167\/iovs.61.4.49","volume":"9","author":"AEG Haarman","year":"2020","unstructured":"Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: A review and Meta-Analysis. Invest Ophthalmol Vis Sci Apr. 2020;9(4):49. https:\/\/doi.org\/10.1167\/iovs.61.4.49.","journal-title":"Invest Ophthalmol Vis Sci Apr"},{"issue":"4","key":"4338_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ophtha.2011.09.025","volume":"119","author":"CF Lee","year":"2012","unstructured":"Lee CF, Cheng AC, Fong DY. Eyes or subjects: are ophthalmic randomized controlled trials properly designed and analyzed? Ophthalmology Apr. 2012;119(4):869\u201372. https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.025.","journal-title":"Ophthalmology Apr"},{"issue":"3","key":"4338_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","volume":"129","author":"A Ha","year":"2022","unstructured":"Ha A, Kim SJ, Shim SR, Kim YK, Jung JH. Efficacy and safety of 8 Atropine concentrations for myopia control in children: A network Meta-Analysis. Ophthalmology Mar. 2022;129(3):322\u201333. https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.016.","journal-title":"Ophthalmology Mar"},{"key":"4338_CR7","doi-asserted-by":"publisher","first-page":"1125000","DOI":"10.3389\/fpubh.2023.1125000","volume":"11","author":"C Lanca","year":"2023","unstructured":"Lanca C, Pang CP, Grzybowski A. Effectiveness of myopia control interventions: A systematic review of 12 randomized control trials published between 2019 and 2021. Front Public Health. 2023;11:1125000. https:\/\/doi.org\/10.3389\/fpubh.2023.1125000.","journal-title":"Front Public Health"},{"key":"4338_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ajo.2023.03.036","volume":"252","author":"J Tang","year":"2023","unstructured":"Tang J, Liao Y, Yan N, et al. Efficacy of repeated Low-Level Red-Light therapy for slowing the progression of childhood myopia: A systematic review and Meta-analysis. Am J Ophthalmol Aug. 2023;252:153\u201363. https:\/\/doi.org\/10.1016\/j.ajo.2023.03.036.","journal-title":"Am J Ophthalmol Aug"},{"issue":"2","key":"4338_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bjophthalmol-2021-319306","volume":"107","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Chen Y, Tan Z, Xiong R, McGuinness MB, M\u00fcller A. Interventions recommended for myopia prevention and control among children and adolescents in china: a systematic review. Br J Ophthalmol Feb. 2023;107(2):160\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319306.","journal-title":"Br J Ophthalmol Feb"},{"key":"4338_CR10","first-page":"254","volume":"15","author":"S Agarwal","year":"2023","unstructured":"Agarwal S, Saxena A, Saxena S. Mridula. Evaluation of the safety and effectiveness of Low-Dose Atropine eye drops in managing myopia progression among. Indian Child 01\/01. 2023;15:254\u201363.","journal-title":"Indian Child 01\/01"},{"issue":"6","key":"4338_CR11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ophtha.2019.09.006","volume":"127","author":"M Ang","year":"2020","unstructured":"Ang M, Farook M, Htoon HM, Mehta JS. Randomized clinical trial comparing femtosecond LASIK and Small-Incision lenticule extraction. Ophthalmology Jun. 2020;127(6):724\u201330. https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.006.","journal-title":"Ophthalmology Jun"},{"issue":"5","key":"4338_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"1","author":"J Bao","year":"2022","unstructured":"Bao J, Huang Y, Li X, et al. Spectacle lenses with aspherical lenslets for myopia control vs Single-Vision spectacle lenses: A randomized clinical trial. JAMA Ophthalmol May. 2022;1(5):472\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.0401.","journal-title":"JAMA Ophthalmol May"},{"issue":"8","key":"4338_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/opx.0000000000001410","volume":"96","author":"P Chamberlain","year":"2019","unstructured":"Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of misight lenses for myopia control. Optom Vis Sci Aug. 2019;96(8):556\u201367. https:\/\/doi.org\/10.1097\/opx.0000000000001410.","journal-title":"Optom Vis Sci Aug"},{"issue":"1","key":"4338_CR14","doi-asserted-by":"publisher","first-page":"11588","DOI":"10.1038\/s41598-022-15686-6","volume":"8","author":"HHL Chan","year":"2022","unstructured":"Chan HHL, Choi KY, Ng ALK, et al. Efficacy of 0.01% Atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response. Sci Rep Jul. 2022;8(1):11588. https:\/\/doi.org\/10.1038\/s41598-022-15686-6.","journal-title":"Sci Rep Jul"},{"issue":"2","key":"4338_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00417-022-05794-4","volume":"261","author":"H Chen","year":"2023","unstructured":"Chen H, Wang W, Liao Y, et al. Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol Feb. 2023;261(2):575\u201384. https:\/\/doi.org\/10.1007\/s00417-022-05794-4.","journal-title":"Graefes Arch Clin Exp Ophthalmol Feb"},{"issue":"10","key":"4338_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1167\/tvst.11.10.33","volume":"3","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xiong R, Chen X, et al. Efficacy comparison of repeated Low-Level red light and Low-Dose Atropine for myopia control: A randomized controlled trial. Transl Vis Sci Technol Oct. 2022;3(10):33. https:\/\/doi.org\/10.1167\/tvst.11.10.33.","journal-title":"Transl Vis Sci Technol Oct"},{"issue":"4","key":"4338_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/apo.0000000000000609","volume":"01","author":"A Chia","year":"2023","unstructured":"Chia A, Ngo C, Choudry N, Yamakawa Y, Tan D. Atropine ophthalmic solution to reduce myopia progression in pediatric subjects: the randomized, Double-Blind multicenter phase II APPLE study. Asia Pac J ophthalmol (Phila). Jul-Aug. 2023;01(4):370\u20136. https:\/\/doi.org\/10.1097\/apo.0000000000000609.","journal-title":"Jul-Aug"},{"key":"4338_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajo.2021.11.013","volume":"237","author":"B Chiang","year":"2022","unstructured":"Chiang B, Valerio GS, Manche EE, Prospective. Randomized contralateral eye comparison of Wavefront-Guided laser in situ keratomileusis and small incision lenticule extraction refractive surgeries. Am J Ophthalmol May. 2022;237:211\u201320. https:\/\/doi.org\/10.1016\/j.ajo.2021.11.013.","journal-title":"Am J Ophthalmol May"},{"issue":"1","key":"4338_CR19","doi-asserted-by":"publisher","first-page":"22267","DOI":"10.1038\/s41598-021-01708-2","volume":"15","author":"C Cui","year":"2021","unstructured":"Cui C, Li X, Lyu Y, et al. Safety and efficacy of 0.02% and 0.01% Atropine on controlling myopia progression: a 2-year clinical trial. Sci Rep Nov. 2021;15(1):22267. https:\/\/doi.org\/10.1038\/s41598-021-01708-2.","journal-title":"Sci Rep Nov"},{"issue":"2","key":"4338_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","volume":"130","author":"J Dong","year":"2023","unstructured":"Dong J, Zhu Z, Xu H, He M. Myopia control effect of repeated Low-Level Red-Light therapy in Chinese children: A randomized, Double-Blind, controlled clinical trial. Ophthalmology Feb. 2023;130(2):198\u2013204. https:\/\/doi.org\/10.1016\/j.ophtha.2022.08.024.","journal-title":"Ophthalmology Feb"},{"issue":"1","key":"4338_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12886-022-02491-y","volume":"24","author":"R Dong","year":"2022","unstructured":"Dong R, Zhang Y, Yuan Y, Liu Y, Wang Y, Chen Y. A prospective randomized self-controlled study of LASIK combined with accelerated cross-linking for high myopia in chinese: 24-month follow-up. BMC Ophthalmol Jun. 2022;24(1):280. https:\/\/doi.org\/10.1186\/s12886-022-02491-y.","journal-title":"BMC Ophthalmol Jun"},{"issue":"8","key":"4338_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/icl.0000000000000911","volume":"1","author":"J Fang","year":"2022","unstructured":"Fang J, Huang Z, Long Y, et al. Retardation of myopia by multifocal soft contact lens and orthokeratology: A 1-Year randomized clinical trial. Eye Contact Lens Aug. 2022;1(8):328\u201334. https:\/\/doi.org\/10.1097\/icl.0000000000000911.","journal-title":"Eye Contact Lens Aug"},{"issue":"1","key":"4338_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/cxo.13077","volume":"104","author":"AM Garcia-Del Valle","year":"2021","unstructured":"Garcia-Del Valle AM, Bl\u00e1zquez V, Gros-Otero J, et al. Efficacy and safety of a soft contact lens to control myopia progression. Clin Exp Optom Jan. 2021;104(1):14\u201321. https:\/\/doi.org\/10.1111\/cxo.13077.","journal-title":"Clin Exp Optom Jan"},{"issue":"4","key":"4338_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/opo.12834","volume":"41","author":"B Guo","year":"2021","unstructured":"Guo B, Cheung SW, Kojima R, Cho P. One-year results of the variation of orthokeratology lens treatment zone (VOLTZ) study: a prospective randomised clinical trial. Ophthalmic Physiol Opt Jul. 2021;41(4):702\u201314. https:\/\/doi.org\/10.1111\/opo.12834.","journal-title":"Ophthalmic Physiol Opt Jul"},{"issue":"2","key":"4338_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/jop.2019.0062","volume":"36","author":"L Guo","year":"2020","unstructured":"Guo L, Fan L, Tao J, et al. Use of topical 0.01% Atropine for controlling near Work-Induced transient myopia: A randomized, Double-Masked, Placebo-Controlled study. J Ocul Pharmacol Ther Mar. 2020;36(2):97\u2013101. https:\/\/doi.org\/10.1089\/jop.2019.0062.","journal-title":"J Ocul Pharmacol Ther Mar"},{"issue":"2","key":"4338_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.11.2.13","volume":"1","author":"S He","year":"2022","unstructured":"He S, Luo Y, Chen P, et al. Prospective, randomized, contralateral eye comparison of functional optical zone, and visual quality after SMILE and FS-LASIK for high myopia. Transl Vis Sci Technol Feb. 2022;1(2):13. https:\/\/doi.org\/10.1167\/tvst.11.2.13.","journal-title":"Transl Vis Sci Technol Feb"},{"issue":"11","key":"4338_CR27","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ophtha.2022.06.024","volume":"129","author":"X He","year":"2022","unstructured":"He X, Sankaridurg P, Wang J, et al. Time outdoors in reducing myopia: A School-Based cluster randomized trial with objective monitoring of outdoor time and light intensity. Ophthalmology Nov. 2022;129(11):1245\u201354. https:\/\/doi.org\/10.1016\/j.ophtha.2022.06.024.","journal-title":"Ophthalmology Nov"},{"issue":"4","key":"4338_CR28","doi-asserted-by":"publisher","first-page":"e239612","DOI":"10.1001\/jamanetworkopen.2023.9612","volume":"3","author":"X He","year":"2023","unstructured":"He X, Wang J, Zhu Z, et al. Effect of repeated Low-level red light on myopia prevention among children in China with premyopia: A randomized clinical trial. JAMA Netw Open Apr. 2023;3(4):e239612. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.9612.","journal-title":"JAMA Netw Open Apr"},{"issue":"3","key":"4338_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","volume":"65","author":"O Hieda","year":"2021","unstructured":"Hieda O, Hiraoka T, Fujikado T, et al. Efficacy and safety of 0.01% Atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study. Jpn J Ophthalmol May. 2021;65(3):315\u201325. https:\/\/doi.org\/10.1007\/s10384-021-00822-y.","journal-title":"Jpn J Ophthalmol May"},{"issue":"6","key":"4338_CR30","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3233\/thc-220893","volume":"31","author":"P Hu","year":"2023","unstructured":"Hu P, Tao L. Comparison of the clinical effects between digital keratoplasty and traditional orthokeratology lenses for correcting juvenile myopia. Technol Health Care. 2023;31(6):2021\u20139. https:\/\/doi.org\/10.3233\/thc-220893.","journal-title":"Technol Health Care"},{"issue":"10","key":"4338_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3928\/1081597x-20220831-01","volume":"38","author":"W Huang","year":"2022","unstructured":"Huang W, Ji Y, Zheng S, et al. The effectiveness and rotational stability of vertical implantation of the implantable collamer lens for the treatment of myopia. J Refract Surg Oct. 2022;38(10):641\u20137. https:\/\/doi.org\/10.3928\/1081597x-20220831-01.","journal-title":"J Refract Surg Oct"},{"key":"4338_CR32","doi-asserted-by":"publisher","unstructured":"Hvid-Hansen A, Jacobsen N, M\u00f8ller F, Bek T, Ozenne B, Kessel L. Myopia control with Low-Dose Atropine in European children: Six-Month results from a randomized, Double-Masked, Placebo-Controlled, multicenter study. J Pers Med Feb. 2023;14(2). https:\/\/doi.org\/10.3390\/jpm13020325.","DOI":"10.3390\/jpm13020325"},{"issue":"2","key":"4338_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/aos.14911","volume":"100","author":"TM Jakobsen","year":"2022","unstructured":"Jakobsen TM, M\u00f8ller F. Control of myopia using orthokeratology lenses in Scandinavian children aged 6 to 12 years. Eighteen-month data from the Danish randomized study: clinical study of Near-sightedness; treatment with orthokeratology lenses (CONTROL study). Acta Ophthalmol Mar. 2022;100(2):175\u201382. https:\/\/doi.org\/10.1111\/aos.14911.","journal-title":"Acta Ophthalmol Mar"},{"issue":"1","key":"4338_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/ijo.IJO_1462_21","volume":"70","author":"J Jethani","year":"2022","unstructured":"Jethani J. Efficacy of low-concentration Atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes. Indian J Ophthalmol Jan. 2022;70(1):238\u201340. https:\/\/doi.org\/10.4103\/ijo.IJO_1462_21.","journal-title":"Indian J Ophthalmol Jan"},{"issue":"5","key":"4338_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","volume":"129","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhu Z, Tan X, et al. Effect of repeated Low-Level Red-Light therapy for myopia control in children: A multicenter randomized controlled trial. Ophthalmology May. 2022;129(5):509\u201319. https:\/\/doi.org\/10.1016\/j.ophtha.2021.11.023.","journal-title":"Ophthalmology May"},{"issue":"3","key":"4338_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3928\/1081597x-20230113-01","volume":"39","author":"FA Jorge","year":"2023","unstructured":"Jorge FA, Taguchi F, Campos M. The 18-Month outcomes of a contralateral, randomized, prospective clinical trial comparing photorefractive keratectomy and SMILE for myopia. J Refract Surg Mar. 2023;39(3):180\u20136. https:\/\/doi.org\/10.3928\/1081597x-20230113-01.","journal-title":"J Refract Surg Mar"},{"issue":"1","key":"4338_CR37","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1038\/s41598-020-69710-8","volume":"29","author":"N Kinoshita","year":"2020","unstructured":"Kinoshita N, Konno Y, Hamada N, et al. Efficacy of combined orthokeratology and 0.01% Atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Sci Rep Jul. 2020;29(1):12750. https:\/\/doi.org\/10.1038\/s41598-020-69710-8.","journal-title":"Sci Rep Jul"},{"key":"4338_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajo.2019.10.024","volume":"211","author":"T Kohnen","year":"2020","unstructured":"Kohnen T, Lwowski C, Hemkeppler E, et al. Comparison of Femto-LASIK with combined accelerated Cross-linking to Femto-LASIK in high myopic eyes: A prospective randomized trial. Am J Ophthalmol Mar. 2020;211:42\u201355. https:\/\/doi.org\/10.1016\/j.ajo.2019.10.024.","journal-title":"Am J Ophthalmol Mar"},{"key":"4338_CR39","doi-asserted-by":"publisher","first-page":"5585441","DOI":"10.1155\/2021\/5585441","volume":"2021","author":"XH Kong","year":"2021","unstructured":"Kong XH, Zhao Y, Chen Z, et al. A randomized controlled trial of the effect of 0.01% Atropine eye drops combined with auricular acupoint stimulation on myopia progression. J Ophthalmol. 2021;2021:5585441. https:\/\/doi.org\/10.1155\/2021\/5585441.","journal-title":"J Ophthalmol"},{"issue":"3","key":"4338_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, et al. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol Mar. 2020;104(3):363\u20138. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739.","journal-title":"Br J Ophthalmol Mar"},{"issue":"1","key":"4338_CR41","doi-asserted-by":"publisher","first-page":"101745","DOI":"10.1016\/j.clae.2022.101745","volume":"46","author":"JK Lau","year":"2023","unstructured":"Lau JK, Wan K, Cho P. Orthokeratology lenses with increased compression factor (OKIC): A 2-year longitudinal clinical trial for myopia control. Cont Lens Anterior Eye Feb. 2023;46(1):101745. https:\/\/doi.org\/10.1016\/j.clae.2022.101745.","journal-title":"Cont Lens Anterior Eye Feb"},{"issue":"9","key":"4338_CR42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ceo.14148","volume":"50","author":"SS Lee","year":"2022","unstructured":"Lee SS, Lingham G, Blaszkowska M, et al. Low-concentration Atropine Eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trial. Clin Exp Ophthalmol Dec. 2022;50(9):1001\u201312. https:\/\/doi.org\/10.1111\/ceo.14148.","journal-title":"Clin Exp Ophthalmol Dec"},{"issue":"11","key":"4338_CR43","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/jamaophthalmol.2021.3695","volume":"1","author":"Q Li","year":"2021","unstructured":"Li Q, Guo L, Zhang J, et al. Effect of School-Based family health education via social media on children\u2019s myopia and parents\u2019 awareness: A randomized clinical trial. JAMA Ophthalmol Nov. 2021;1(11):1165\u201372. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.3695.","journal-title":"JAMA Ophthalmol Nov"},{"issue":"11","key":"4338_CR44","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/jamapediatrics.2022.3542","volume":"1","author":"SM Li","year":"2022","unstructured":"Li SM, Ran AR, Kang MT, et al. Effect of text messaging parents of School-Aged children on outdoor time to control myopia: A randomized clinical trial. JAMA Pediatr Nov. 2022;1(11):1077\u201383. https:\/\/doi.org\/10.1001\/jamapediatrics.2022.3542.","journal-title":"JAMA Pediatr Nov"},{"issue":"6","key":"4338_CR45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/aos.15649","volume":"101","author":"X Liu","year":"2023","unstructured":"Liu X, Wang P, Xie Z, et al. One-year myopia control efficacy of cylindrical annular refractive element spectacle lenses. Acta Ophthalmol Sep. 2023;101(6):651\u20137. https:\/\/doi.org\/10.1111\/aos.15649.","journal-title":"Acta Ophthalmol Sep"},{"key":"4338_CR46","doi-asserted-by":"publisher","unstructured":"Mori K, Torii H, Fujimoto S, et al. The effect of dietary supplementation of Crocetin for myopia control in children: A randomized clinical trial. J Clin Med Aug. 2019;7(8). https:\/\/doi.org\/10.3390\/jcm8081179.","DOI":"10.3390\/jcm8081179"},{"key":"4338_CR47","doi-asserted-by":"publisher","unstructured":"Mori K, Torii H, Hara Y, et al. Effect of Violet Light-Transmitting eyeglasses on axial elongation in myopic children: A randomized controlled trial. J Clin Med Nov. 2021;22(22). https:\/\/doi.org\/10.3390\/jcm10225462.","DOI":"10.3390\/jcm10225462"},{"issue":"12","key":"4338_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/icl.0000000000001043","volume":"1","author":"T Peng","year":"2023","unstructured":"Peng T, Jiang J. Efficiency and related factors of multifocal soft contact lenses in controlling myopia. Eye Contact Lens Dec. 2023;1(12):535\u201341. https:\/\/doi.org\/10.1097\/icl.0000000000001043.","journal-title":"Eye Contact Lens Dec"},{"issue":"2","key":"4338_CR49","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1111\/aos.14078","volume":"98","author":"Y Qian","year":"2020","unstructured":"Qian Y, Chen X, Naidu RK, Zhou X. Comparison of efficacy and visual outcomes after SMILE and FS-LASIK for the correction of high myopia with the sum of myopia and astigmatism from \u2013\u200910.00 to -14.00 dioptres. Acta Ophthalmol Mar. 2020;98(2):e161\u201372. https:\/\/doi.org\/10.1111\/aos.14078.","journal-title":"Acta Ophthalmol Mar"},{"issue":"4","key":"4338_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4103\/1319-4534.347305","volume":"35","author":"LH Raffa","year":"2021","unstructured":"Raffa LH, Allinjawi K, Sharanjeet K, Akhir SM, Mutalib HA. Myopia control with soft multifocal contact lenses: 18-month follow-up. Saudi J Ophthalmol Oct-Dec. 2021;35(4):325\u201331. https:\/\/doi.org\/10.4103\/1319-4534.347305.","journal-title":"Saudi J Ophthalmol Oct-Dec"},{"issue":"11","key":"4338_CR51","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1136\/bjo-2021-321005","volume":"107","author":"J Rappon","year":"2023","unstructured":"Rappon J, Chung C, Young G, et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). Br J Ophthalmol Nov. 2023;107(11):1709\u201315. https:\/\/doi.org\/10.1136\/bjo-2021-321005.","journal-title":"Br J Ophthalmol Nov"},{"key":"4338_CR52","doi-asserted-by":"publisher","first-page":"9212253","DOI":"10.1155\/2022\/9212253","volume":"2022","author":"M Rateb","year":"2022","unstructured":"Rateb M, Gad AAM, Tohamy D, Elmohamady MN. A prospective comparative study between implantable Phakic intraocular contact lens and implantable collamer lens in treatment of myopia in adults. J Ophthalmol. 2022;2022:9212253. https:\/\/doi.org\/10.1155\/2022\/9212253.","journal-title":"J Ophthalmol"},{"issue":"6","key":"4338_CR53","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.clae.2020.03.016","volume":"43","author":"Q Ren","year":"2020","unstructured":"Ren Q, Yang B, Liu L, Cho P. Orthokeratology in adults and factors affecting success: study design and preliminary results. Cont Lens Anterior Eye Dec. 2020;43(6):595\u2013601. https:\/\/doi.org\/10.1016\/j.clae.2020.03.016.","journal-title":"Cont Lens Anterior Eye Dec"},{"issue":"8","key":"4338_CR54","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","volume":"1","author":"MX Repka","year":"2023","unstructured":"Repka MX, Weise KK, Chandler DL, et al. Low-Dose 0.01% Atropine eye drops vs placebo for myopia control: A randomized clinical trial. JAMA Ophthalmol Aug. 2023;1(8):756\u201365. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2855.","journal-title":"JAMA Ophthalmol Aug"},{"issue":"4","key":"4338_CR55","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/opo.12621","volume":"39","author":"P Sankaridurg","year":"2019","unstructured":"Sankaridurg P, Bakaraju RC, Naduvilath T, et al. Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial. Ophthalmic Physiol Opt Jul. 2019;39(4):294\u2013307. https:\/\/doi.org\/10.1111\/opo.12621.","journal-title":"Ophthalmic Physiol Opt Jul"},{"key":"4338_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajo.2022.10.021","volume":"247","author":"P Sankaridurg","year":"2023","unstructured":"Sankaridurg P, Weng R, Tran H, et al. Spectacle lenses with highly aspherical lenslets for slowing myopia: A randomized, Double-Blind, Cross-Over clinical trial: parts of these data were presented as a poster at the annual research in vision and ophthalmology meeting, 2022. Am J Ophthalmol Mar. 2023;247:18\u201324. https:\/\/doi.org\/10.1016\/j.ajo.2022.10.021.","journal-title":"Am J Ophthalmol Mar"},{"issue":"9","key":"4338_CR57","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","volume":"128","author":"R Saxena","year":"2021","unstructured":"Saxena R, Dhiman R, Gupta V, et al. Atropine for the treatment of childhood myopia in india: multicentric randomized trial. Ophthalmology Sep. 2021;128(9):1367\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2021.01.026.","journal-title":"Ophthalmology Sep"},{"issue":"9","key":"4338_CR58","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.4103\/ijo.IJO_256_22","volume":"70","author":"S Sen","year":"2022","unstructured":"Sen S, Yadav H, Jain A, Verma S, Gupta P. Effect of Atropine 0.01% on progression of myopia. Indian J Ophthalmol Sep. 2022;70(9):3373\u20136. https:\/\/doi.org\/10.4103\/ijo.IJO_256_22.","journal-title":"Indian J Ophthalmol Sep"},{"issue":"4","key":"4338_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1080\/02713683.2022.2162925","volume":"48","author":"I Sharma","year":"2023","unstructured":"Sharma I, Das GK, Rohatgi J, Sahu PK, Chhabra P, Bhatia R. Low dose Atropine in preventing the progression of childhood myopia: A randomised controlled trial. Curr Eye Res Apr. 2023;48(4):402\u20137. https:\/\/doi.org\/10.1080\/02713683.2022.2162925.","journal-title":"Curr Eye Res Apr"},{"key":"4338_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.7897\/2277-4343.1306151","volume":"12\/05","author":"V Shekar","year":"2022","unstructured":"Shekar V, K S. MYOPIA MANAGEMENT WITH AYURVEDIC OCULAR VH. THERAPEUTICS: A CLINICAL STUDY. Int J Res Ayurveda Pharm. 2022;12\/05:13:23\u20137. https:\/\/doi.org\/10.7897\/2277-4343.1306151.","journal-title":"Int J Res Ayurveda Pharm"},{"issue":"1","key":"4338_CR61","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.clae.2022.101723","volume":"46","author":"Q Tan","year":"2023","unstructured":"Tan Q, Ng AL, Cheng GP, Woo VC, Cho P. Combined 0.01% Atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Cont Lens Anterior Eye Feb. 2023;46(1):101723. https:\/\/doi.org\/10.1016\/j.clae.2022.101723.","journal-title":"Cont Lens Anterior Eye Feb"},{"issue":"10","key":"4338_CR62","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1007\/s10792-023-02762-7","volume":"43","author":"L Tian","year":"2023","unstructured":"Tian L, Cao K, Ma DL, et al. Six-month repeated irradiation of 650 Nm low-level red light reduces the risk of myopia in children: a randomized controlled trial. Int Ophthalmol Oct. 2023;43(10):3549\u201358. https:\/\/doi.org\/10.1007\/s10792-023-02762-7.","journal-title":"Int Ophthalmol Oct"},{"issue":"11","key":"4338_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/tvst.10.11.18","volume":"1","author":"JSH Tse","year":"2021","unstructured":"Tse JSH, Cheung JKW, Wong GTK, et al. Integrating clinical data and tear proteomics to assess efficacy, ocular surface status, and biomarker response after orthokeratology lens wear. Transl Vis Sci Technol Sep. 2021;1(11):18. https:\/\/doi.org\/10.1167\/tvst.10.11.18.","journal-title":"Transl Vis Sci Technol Sep"},{"issue":"6","key":"4338_CR64","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2020.10834","volume":"11","author":"JJ Walline","year":"2020","unstructured":"Walline JJ, Walker MK, Mutti DO, et al. Effect of high add power, medium add power, or Single-Vision contact lenses on myopia progression in children: the BLINK randomized clinical trial. Jama Aug. 2020;11(6):571\u201380. https:\/\/doi.org\/10.1001\/jama.2020.10834.","journal-title":"Jama Aug"},{"issue":"11","key":"4338_CR65","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","volume":"1","author":"S Wei","year":"2020","unstructured":"Wei S, Li SM, An W, et al. Safety and efficacy of Low-Dose Atropine Eyedrops for the treatment of myopia progression in Chinese children: A randomized clinical trial. JAMA Ophthalmol Nov. 2020;1(11):1178\u201384. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3820.","journal-title":"JAMA Ophthalmol Nov"},{"issue":"6","key":"4338_CR66","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/opo.13042","volume":"42","author":"R Weng","year":"2022","unstructured":"Weng R, Lan W, Bakaraju R, et al. Efficacy of contact lenses for myopia control: insights from a randomised, contralateral study design. Ophthalmic Physiol Opt Nov. 2022;42(6):1253\u201363. https:\/\/doi.org\/10.1111\/opo.13042.","journal-title":"Ophthalmic Physiol Opt Nov"},{"key":"4338_CR67","doi-asserted-by":"publisher","unstructured":"Xia L, Zhao H, Wang Y. Effect of 0.01% Atropine on diopter and optic axis in adolescents and children with myopia. J Pak Med Assoc. Mar 2023;73(3):656\u20138. https:\/\/doi.org\/10.47391\/jpma.6241.","DOI":"10.47391\/jpma.6241"},{"issue":"12","key":"4338_CR68","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/bjo-2022-321272","volume":"22","author":"S Xu","year":"2023","unstructured":"Xu S, Li Z, Zhao W, et al. Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trial. Br J Ophthalmol Nov. 2023;22(12):1812\u20137. https:\/\/doi.org\/10.1136\/bjo-2022-321272.","journal-title":"Br J Ophthalmol Nov"},{"issue":"7","key":"4338_CR69","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X, et al. Two-Year clinical trial of the Low-Concentration Atropine for myopia progression (LAMP) study: phase 2 report. Ophthalmology Jul. 2020;127(7):910\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2019.12.011.","journal-title":"Ophthalmology Jul"},{"issue":"6","key":"4338_CR70","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","volume":"14","author":"JC Yam","year":"2023","unstructured":"Yam JC, Zhang XJ, Zhang Y, et al. Effect of Low-Concentration Atropine Eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial. Jama Feb. 2023;14(6):472\u201381. https:\/\/doi.org\/10.1001\/jama.2022.24162.","journal-title":"Jama Feb"},{"issue":"5","key":"4338_CR71","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/02713683.2020.1820528","volume":"46","author":"X Yang","year":"2021","unstructured":"Yang X, Bi H, Li L, et al. The effect of relative corneal refractive power shift distribution on axial length growth in myopic children undergoing orthokeratology treatment. Curr Eye Res May. 2021;46(5):657\u201365. https:\/\/doi.org\/10.1080\/02713683.2020.1820528.","journal-title":"Curr Eye Res May"},{"issue":"1","key":"4338_CR72","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12886-022-02635-0","volume":"15","author":"S Yu","year":"2022","unstructured":"Yu S, Du L, Ji N, et al. Combination of orthokeratology lens with 0.01% Atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial. BMC Ophthalmol Nov. 2022;15(1):438. https:\/\/doi.org\/10.1186\/s12886-022-02635-0.","journal-title":"BMC Ophthalmol Nov"},{"key":"4338_CR73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajo.2023.08.019","volume":"257","author":"C Yuval","year":"2024","unstructured":"Yuval C, Otzem C, Laura BS, et al. Evaluating the effect of a myopia control spectacle lens among children in israel: 12-Month results. Am J Ophthalmol Jan. 2024;257:103\u201312. https:\/\/doi.org\/10.1016\/j.ajo.2023.08.019.","journal-title":"Am J Ophthalmol Jan"},{"issue":"10","key":"4338_CR74","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jamaophthalmol.2023.2097","volume":"1","author":"K Zadnik","year":"2023","unstructured":"Zadnik K, Schulman E, Flitcroft I, et al. Efficacy and safety of 0.01% and 0.02% Atropine for the treatment of pediatric myopia progression over 3 years: A randomized clinical trial. JAMA Ophthalmol Oct. 2023;1(10):990\u20139. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2097.","journal-title":"JAMA Ophthalmol Oct"},{"issue":"1","key":"4338_CR75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12886-022-02443-6","volume":"23","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li T, Li Z, Dai M, Wang Q, Xu C. Clinical outcomes of single-step transepithelial photorefractive keratectomy and off-flap epipolis-laser in situ keratomileusis in moderate to high myopia: 12-month follow-up. BMC Ophthalmol May. 2022;23(1):234. https:\/\/doi.org\/10.1186\/s12886-022-02443-6.","journal-title":"BMC Ophthalmol May"},{"issue":"3","key":"4338_CR76","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10792-020-01658-0","volume":"41","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Hao Q. Clinical efficacy of 0.01% Atropine in retarding the progression of myopia in children. Int Ophthalmol Mar. 2021;41(3):1011\u20137. https:\/\/doi.org\/10.1007\/s10792-020-01658-0.","journal-title":"Int Ophthalmol Mar"},{"issue":"5","key":"4338_CR77","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/09286586.2021.1875010","volume":"28","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Hao Q. Comparison of the clinical efficacies of 0.01% Atropine and orthokeratology in controlling the progression of myopia in children. Ophthalmic Epidemiol Oct. 2021;28(5):376\u201382. https:\/\/doi.org\/10.1080\/09286586.2021.1875010.","journal-title":"Ophthalmic Epidemiol Oct"},{"issue":"3","key":"4338_CR78","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3928\/1081597x-20201230-01","volume":"37","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhang L, Ma J, et al. Comparison of Wavefront-Guided femtosecond LASIK and optimized SMILE for correction of Moderate-to-High astigmatism. J Refract Surg Mar. 2021;37(3):166\u201373. https:\/\/doi.org\/10.3928\/1081597x-20201230-01.","journal-title":"J Refract Surg Mar"},{"issue":"1","key":"4338_CR79","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1038\/s41598-023-30500-7","volume":"27","author":"L Zhou","year":"2023","unstructured":"Zhou L, Tong L, Li Y, Williams BT, Qiu K. Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence. Sci Rep Feb. 2023;27(1):3321. https:\/\/doi.org\/10.1038\/s41598-023-30500-7.","journal-title":"Sci Rep Feb"},{"issue":"1","key":"4338_CR80","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ophtha.2023.08.020","volume":"131","author":"W Zhou","year":"2024","unstructured":"Zhou W, Liao Y, Wang W, et al. Efficacy of different powers of Low-Level red light in children for myopia control. Ophthalmology Jan. 2024;131(1):48\u201357. https:\/\/doi.org\/10.1016\/j.ophtha.2023.08.020.","journal-title":"Ophthalmology Jan"},{"issue":"6","key":"4338_CR81","doi-asserted-by":"publisher","first-page":"939","DOI":"10.18240\/ijo.2023.06.17","volume":"16","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Tang GY, Hua ZJ, et al. 0.05% Atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial. Int J Ophthalmol. 2023;16(6):939\u201346. https:\/\/doi.org\/10.18240\/ijo.2023.06.17.","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"4338_CR82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.7150\/ijms.79496","volume":"20","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Yin J, Li X, et al. Effects of Long-Term wear and discontinuation of orthokeratology lenses on the eyeball parameters in children with myopia. Int J Med Sci. 2023;20(1):50\u20136. https:\/\/doi.org\/10.7150\/ijms.79496.","journal-title":"Int J Med Sci"},{"issue":"1","key":"4338_CR83","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12886-022-02293-2","volume":"11","author":"H Hashemi","year":"2022","unstructured":"Hashemi H, Alvani A, Aghamirsalim M, Miraftab M, Asgari S. Comparison of transepithelial and conventional photorefractive keratectomy in myopic and myopic astigmatism patients: a randomized contralateral trial. BMC Ophthalmol Feb. 2022;11(1):68. https:\/\/doi.org\/10.1186\/s12886-022-02293-2.","journal-title":"BMC Ophthalmol Feb"},{"issue":"2","key":"4338_CR84","doi-asserted-by":"publisher","first-page":"100266","DOI":"10.1016\/j.xops.2022.100266","volume":"3","author":"R Dong","year":"2023","unstructured":"Dong R, Ying GS. Characteristics of design and analysis of ophthalmic randomized controlled trials: A review of ophthalmic papers 2020\u20132021. Ophthalmol Sci Jun. 2023;3(2):100266. https:\/\/doi.org\/10.1016\/j.xops.2022.100266.","journal-title":"Ophthalmol Sci Jun"},{"issue":"1","key":"4338_CR85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaophthalmol.2014.3600","volume":"133","author":"AR Glassman","year":"2015","unstructured":"Glassman AR, Melia M. Randomizing 1 eye or 2 eyes: a missed opportunity. JAMA Ophthalmol Jan. 2015;133(1):9\u201310. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.3600.","journal-title":"JAMA Ophthalmol Jan"},{"issue":"2","key":"4338_CR86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/jovr.jovr_196_17","volume":"13","author":"A Bagheri","year":"2018","unstructured":"Bagheri A, Feizi M, Shafii A, Faramarzi A, Tavakoli M, Yazdani S. Effect of cycloplegia on corneal biometrics and refractive state. J Ophthalmic Vis Res Apr-Jun. 2018;13(2):101\u20139. https:\/\/doi.org\/10.4103\/jovr.jovr_196_17.","journal-title":"J Ophthalmic Vis Res Apr-Jun"},{"issue":"6","key":"4338_CR87","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1444-0938.2009.00419.x","volume":"92","author":"SW Cheung","year":"2009","unstructured":"Cheung SW, Chan R, Cheng RC, Cho P. Effect of cycloplegia on axial length and anterior chamber depth measurements in children. Clin Exp Optom Nov. 2009;92(6):476\u201381. https:\/\/doi.org\/10.1111\/j.1444-0938.2009.00419.x.","journal-title":"Clin Exp Optom Nov"},{"issue":"122","key":"4338_CR88","first-page":"14","volume":"37","author":"M Ho","year":"2024","unstructured":"Ho M, Morjaria P. Cycloplegic refraction in children. Community Eye Health. 2024;37(122):14\u20135.","journal-title":"Community Eye Health"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04338-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04338-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04338-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:07:47Z","timestamp":1759230467000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04338-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4338"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04338-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"510"}}